Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Hair shaft miniaturization leads to hair follicle stem cell loss, suggesting Piezo1 as a potential treatment target.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Combination therapies might work better for some vitiligo patients, but results vary.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Removing a hormone-producing adrenal tumor can stop hair loss in women with high testosterone levels.

COVID-19 vaccination may trigger lupus in some people.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Corticosteroids can reduce scarring in acne keloidalis by targeting specific cells.

Probiotics may help treat skin conditions like acne and eczema safely.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

ERG increases SOX9, promoting prostate cancer growth and invasion.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Interleukin-1 increases keratin K6 production in skin cells.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

The study found key genes and pathways involved in cashmere goat hair growth stages.

Vitamin D receptor may help protect against UV-induced skin cancer.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Bidens pilosa L. extract effectively treats androgen deficiency dry eye in rats.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Omega-6 fats in certain cells boost male hormone production.